bioMérieux - First-Half 2010 Business Review

22 July, 2010

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2010.

Net sales for the first half of 2010 reached €651 million, a 6% year-on-year increase at constant exchange rates and scope of consolidation (like-for-like).

Sales: €651 million

  • Up 6% at constant exchange rates and scope of consolidation
  • Strong performance of clinical and industrial microbiology as well as VIDAS®
  • Robust growth in emerging countries
  • 2010 operating margin objective confirmed
Download
Pioneering Diagnostics